CJWWX - LONG RANGER GEL SOLUTION, F17-38-9-1

  • MSDS: CJWWX
  • Manufacturer: FMC CORP
  • Product Name: LONG RANGER GEL SOLUTION, F17-38-9-1
  • National Stock Number: 6810-00N092199
Product Identification

Product ID:LONG RANGER GEL SOLUTION, F17-38-9-1
MSDS Date:05/01/1997
FSC:6810
NIIN:00N092199
Status Code:A
MSDS Number: CJWWX

Responsible Party
FMC CORPORATION
191 THOMASTON STREET
ROCKLAND, ME 04841
US

Emergency Phone: 202-483-7616

Info Phone: 800-521-0390; 207-594-3400

Cage: 61382

Contractor
FMC CORPORATION
ROCKLAND, ME 04841 US

Telephone: 800-521-0390; 207-594-3400

Cage: 61382

Ingredients

WATER

CAS: 7732-18-5

RTECS: ZC0110000

OSHA PEL N/K

ACGIH TLV: N/K


ACRYLAMIDE

CAS: 79-06-1

RTECS: AS3325000

OSHA PEL 0.3 MG/M3

ACGIH TLV: 0.03 MG/M3

EPA Report Quantity: 5000 LBS

DOT Report Quantity: 5000 LBS


FORMALDEHYDE

CAS: 50-00-0

RTECS: LP8925000

OSHA PEL see 1910.1048

ACGIH TLV: N/K

EPA Report Quantity: 100 LBS

DOT Report Quantity: 100 LBS


N-METHYLOLACRYLAMIDE (NMA). (PRODUCT MAY CONTAIN ONE OR

CAS: 924-42-5

RTECS: AS3600000

OSHA PEL N/K

ACGIH TLV: N/K


BIS-ACRYLAMIDE DIMETHYL ETHER

CAS: 16958-71-7

OSHA PEL N/K

ACGIH TLV: N/K


DIACETONE ACRYLAMIDE

CAS: 2873-97-4

RTECS: AS3475000

OSHA PEL N/K

ACGIH TLV: N/K


DI(ETHYLENE GLYCOL) DI-ACRYLATE (DEGDA)

CAS: 4074-88-8

OSHA PEL N/K

ACGIH TLV: N/K


TETRA (ETHYLENE GLYCOL) DIACRYLATE (TREGDA)

CAS: 17831-71-9

RTECS: AS8100000

OSHA PEL N/K

ACGIH TLV: N/K


N, N'-METHYLENE-BIS-ACRYLAMIDE

CAS: 110-26-9

RTECS: AS3678000

OSHA PEL N/K

ACGIH TLV: N/K

Hazards

LD50 LC50 Mixture:SEE TOXICOLOGICAL INFORMATION.
Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:YES IARC:YES OSHA:YES
Health Hazards Acute and Chronic:CARCINOGENIC: ACRYLAMIDE IS A PROBABLE
HUMAN CARCINOGEN AND A HUMAN NEUROTOXIN. ANOTHER MINOR COMPONENT
HAS BEEN SHOWN TO CAUSE CANCER IN LABORATORY ANIMALS AND IS ALSO
NEUROTOXIC. MAY BE IRRITATING T O EYES, SKIN AND RESPIRATORY TRACT.
EXPOSURE TO FORMALDEHYDE MAY PRODUCE ALLERGIC RESPIRATORY EFFECTS
IN SENSITIZED INDIVIDUALS, INCLUDING ASTHMA, COUGHING, WHEEZING,
SHORTNESS OF BREATH. FORMALDEHYDE IS ALSO CONSIDERED A PROBABLE
HUMAN CARCINOGEN.
Explanation of Carcinogenicity:ACRYLAMIDE: IARC MONO, SUPP, VOL 7, PG
56, 1998: GROUP 2B. NTP 8TH ANNUAL RPT ON CARCINS, 1998: REASONABLY
ANTIC TO BE HUMAN CARCIN. ANIMAL: CNS TOXIN, NEOPLASMS.
FORMALDEHYDE: IARC MONO, SUPP, VOL 62 , PG 217, 1998: GROUP 2A. NTP
8TH ANNUAL RPT ON CARCINS, 1998: REASONABLY ANTIC TO BE HUMAN
CARCIN. OSHA REGULATED: 29 CFR 1910.1048. ANIMAL: NASAL TUMORS.
Effects of Overexposure:SEE HLTH HAZS. STATE REGS: RPTD/LONG TERM EXPOS
MAY PRDCE ALLERGIC SKIN DERM AS WELL AS RESP SENSIT. WORKPLACE
EXPOS TO FORMALDEHYDE MAY CAUSE DISTURBED SLEEP, UNUSUAL THIRST;
LOSS OF SMELL, INCRD UPP ER RESP DISEASE, CHRONIC AIRWAY
OBSTRUCTION, BRTHG PROBLEMS, MENSTRUAL DISORDERS, PREGNANCY
COMPLICATIONS, LOW BIRTH WT IN ADDN TO IRRITANT EFTS AT LEVELS UP
TO 4 PPM. TETRAETHYLENE DIACRYLATE HAS COR R TO SKIN WHEN
ADMINISTERED DAILY FOR A PERIOD OF 2 WKS. THERE WERE NO OTHER TOX
EFTS NOTED IN STUDY. IT WAS MUTAGENIC IN MOUSE LYMPHOMA ASSAY &
RSLTS INDICATED THAT IT MAY HAVE POTENTIAL FOR CHROMOSO ME DMG.

First Aid

First Aid:EYES: FLUSH W/WATER FOR AT LEAST 15 MINS. IF IRRIT OCCURS &
PERSISTS, CONT MD. SKIN: REMOVE CONTAM CLTHG & SHOES & THORO WASH
W/SOAP & WATER. IF IRRIT OCCURS & PERSISTS, CONT MD. INHAL: REMOVE
TO FRES H AIR. IF BRTHG DFCLTY/DISCOMFORT OCCURS& PERSISTS, CONT
MD. INGEST: DRINK 1-2 GLASSES OF WATER & INDUCE VOMIT BY TOUCHING
BACK OF THROAT W/FINGER OR BY GIVING SYRUP OF IPECAC. NEVER INDUCE
VOMIT/GIVE ANYTHING BY MOUTH TO AN UNCON PERS. SEE MD. NOTES TO
MD: LONG RANGER GEL SOLN IS ANTIC TO BE MOD IRRITATING TO EYES &
RESP TRACT. ACRYLAMIDE IS A HUMAN NEUROTOXIN W/BOTH CENTRAL &
PERIPHERAL NERV SYS EFTS & NO SPECIFIC ANTIDOTE. (SUP DAT)

Fire Fighting

Extinguishing Media:USE CARBON DIOXIDE, DRY CHEMICAL POWDER, ALCOHOL OR
POLYMER FOAM, OR WATER SPRAY.
Fire Fighting Procedures:WEAR NIOSH APPROVED SELF-CONTAINED BREATHING
APPARATUS AND FULL PROTECTIVE EQUIPMENT .
Unusual Fire/Explosion Hazard:NEGLIGIBLE FIRE HAZARD WHEN EXPOSED TO
HEAT OR FLAME. BURNING MAY PRODUCE CARBON MONOXIDE AND/OR CARBON
DIOXIDE, AMMONIA, AND NITROUS OXIDES.

Accidental Release

Spill Release Procedures:ABSORB ON ABSORBENT MATERIAL AND PLACE INTO
CLOSED CONTAINERS FOR LATER DISPOSAL. FLUSH AREA WITH WATER.
MATERIAL SUBLIMES; THEREFORE, CLEAN UP ALL SPILLS BEFORE THEY DRY.
FOR PERSONAL PRECAUTIONS, SE E CONTROL MEASURES SECTION.

Handling

Handling and Storage Precautions:STORE IN A COOL (<25C) DRY AREA AWAY
FROM COMBUSTIBLES.

Exposure Controls

Respiratory Protection:USE EXHAUST VENTILATION OR WEAR RESPIRATORS
WHICH ARE APPROVED BY NIOSH, EC CEN, OR OTHER COMPARABLE
CERTIFICATION ORGANIZATIONS.
Ventilation:USE EXHAUST VENTILATION.
Protective Gloves:CHEMICAL-RESISTANT GLOVES SHOULD BE WORN.
Eye Protection:ANSI APPROVED CHEMICAL WORKERS GOGGLES .
Other Protective Equipment:ANSI APPROVED EMERGENCY EYEWASH AND DELUGE
SHOWER . LAB COAT OR EQUIVALENT RECOMMENDED.
Work Hygienic Practices:AVOID ALL CONTACT. CAREFUL PERSONAL HYGIENE IS
A NECESSITY.
Supplemental Safety and Health
FIRST AID PROC: TREATMENT IS CONTROLLED REMOVAL OF EXPOS W/SYMPTOMATIC
& SUPPORTIVE CARE. PHYSICAL/CHEM PROPERTIES: % VOLATILES: 50-70
WATER.

Chemical Properties

Boiling Pt:=100.C, 212.F
pH:6.8
Evaporation Rate & Reference:AS WATER
Solubility in Water:AQUEOUS SOLUTION
Appearance and Odor:CLEAR OR COLORLESS AQUEOUS SOLUTION.

Stability

Stability Indicator/Materials to Avoid:YES
AVOID STRONG OXIDIZERS, ACIDS, BASES, AND VINYL POLYMERIZATION
INITIATORS. ALSO AVOID CONTAMINATION WITH IRON, COPPER, ALUMINUM,
BRASS, AND BRONZE.
Hazardous Decomposition Products:UNDER A FIRE IT CAN RELEASE TOXIC
FUMES OF CARBON MONOXIDE, CARBON DIOXIDE, AMMONIA, AND NITROGEN
OXIDES.
Conditions to Avoid Polymerization:EXPOS TO HEAT/ULTRAVIOLET LIGHT. IF
POLYM OCCURS IN CLSD CONTR, SUFFICIENT HEAT & PRESS MAY BE
GENERATED TO RUPTURE CONTR.

Disposal

Waste Disposal Methods:DISPOSE IN ACCORDANCE WITH APPLICABLE LOCAL,
STATE/PROVINCIAL, AND FEDERAL/NATIONAL REGULATIONS.

Toxicology

Toxicological Information:SKIN CONT: NO DATA AVAIL FOR FORMULATION.
ACRYLAMIDE: MILD TO MOD IRRITANT (RABBIT) DOC TLV'S 1986, GOSSELIN
1984. FORMALDEHYDE: MOD IRRITANT (RABBIT), MILD IRRITANT (HUMAN),
RTECS 1985, SKIN SENSITIZ ER, IARC 1982. NMA: MILD TO MOD IRRITANT
(RABBIT), NTP TRS 352. DEGDA: CORR; SEV IRRITATING SKIN SENSITIZER,
PATTY'S 1194, J. TOXICOL. ENVIRON HLTH 19:149 1986. TREDGA: MOD
IRRITANT (RABBIT); RPTD EXP OS (2 WKS) CORR SKIN SENSITIZER, J
TOXICOL ENVIRON HLTH 19:149 1986. SKIN ABSORPTION: DERMAL LD50
>1000 MG/KG (RABBIT) NO MORTALITY. 197-2199. INHAL: NO DATA AVAIL
FOR FORMULATION. NMA: LC50=5 MG/L (4 HR, RAT) CYTEC MSDS
(ECOLOGICAL INFO)

Other Information

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.

Ecology

Ecological:ENVIRON FATE, ENVIRON EFT: NO DATA AVAIL. TOXICITY INFO:
1994. FORMALDEHYDE: LC50=0.59 MG/L (RAT) RESP SENSITIZER, RTECS
1985, DOC TLV'S 1991. INGEST: ORAL LD50 >500 MG/KG (RAT), 197-2198.
EYES: NO DA TA AVAIL FOR FORMULATION. ACRYLAMIDE: MOD TO SEV IRRIT
(RABBIT), DOC TLV'S 1986, GOSSELIN 1984, RTECS 1983. FORMALDEHYDE:
SEV IRRITANT, RTECS 1985. NMA: MILD TO MOD IRRITANT. NTP TRS 352.
DEGDA: CORR; SEV IRRITATING, PATTY'S 1194, J TOXICOL ENVIRON HLTH
19:149 1986. TREDGA: CORR, J TOXICOL ENVIRON HLTH 19:149 1986.
ACUTE EFTS FROM OVEREXP: LONG RANGER MAY BE HARMFUL BY INGEST.
(TRANSPORTATION INFO )

Transport

Transport Information:U.S. DOT/ICAO/IATA/CANADA (TDG): NON HAZ.
ECOLOGICAL INFO: ACRYLAMIDES ARE READILY ABSORBED THRU SKIN & BY
INHAL & ARE IRRITATING TO SKIN, EYES & RESP TRACT. FORMALDEHYDE
CAUSES IRRIT OF EYES, NOSE, T HROAT & RESP TRACT AT LOW CONCS (<1
PPM). DFCLTY IN BRTHG MAY OCCUR AT 10-20 PPM, W/SERIOUS INJURY TO
RESP TRACT AT 50 PPM. EXPOS TO FORMALDEHYDE MAY PRDCE ALLERGIC RESP
EFTS, INCL ASTHMA, IN SENSITIZ ED INDIVIDUALS. DIETHYLENE GLYCOL
DIACRYLATE IS CORR TO EYES (CAUSES SEV CORNEAL DMG) & SKIN, & HAS
BEEN REPORTED TO BE A SKIN SENSITIZER. TETRAETHYLENE GLYCOL
DIACRYLATE IS MOD IRRITATING TO SKIN W/A CUTE EXPOS & CORR TO EYES.
(SARA REGS)

Regulatory

SARA Title III Information:NOT LISTED. SECTION 311/312: NOT LISTED.
SECTION 313 (40 CFR 372): NOT LISTED. TRANSPORT INFO: IT HAS ALSO
BEEN REPORTED AS A SKIN SENSITIZER. CHRONIC EFTS OF OVEREXP: NO
DATA AVAIL FOR FORMULATION. A CRYLAMIDE & N-METHYLOACRYLAMIDE ARE
HUMAN NEUROTOXINS CAUSING DMG TO BOTH CENTRAL & PERIPHERAL NERV
SYS. SYMPS INCL MUSC WEAK (PARTICULARLY IN LOWER LIMBS), ATAXIA,
TREMORS, NUMBNESS, & TINGLING. NEUR OTOXICITY PRDCED BY DERMAL
EXPOS MAY BE PRECEDED BY PEELING & REDNESS OF SKIN ON HANDS & FEET.
CONT DERM HAS BEEN REPORTED W/ACRYLAMIDES. TESTICULAR DEGENERATION
AS WELL AS REDUCED SPERM MOTILITY, IMP AIRED FERTILITY & DOMINANT
(STATE REGS)
Federal Regulatory Information:U.S. TSCA INVENTORY: FORMULATION IS NOT
LISTED. ACRYLAMIDE & FORMALDEHYDE ARE LISTED. CANADA WHMIS: D, 2A
(VETY TOX MATL, CARCIN, MUTAGEN RESP SENSITIZER) D.2B (OTHER TOX
EFTS). EINECS #: NONE FOR FOR MULATION. [ACRYLAMIDE-201-173-7;
FORMALDEHYDE-200-001-8]. EC SYMBOLS: T (TOX). EC RISK PHRASES: R45
MAY CAUSE CANCER; R46 MAY CAUSE HERITABLE GENETIC DMG; R24/25 TOX
IN CONT W/SKIN & IF SWALLOWED; R48 /23/24/25 TOX: DANGER OT SERIOUS
DMG TO HLTH & PRLNG EXPOS THRU INHAL, IN CONT W/SKIN & IF SWALLOWED
. EC SFTY PHRASES: S53 AVOID EXPOS-OBTAIN MED INSTRUCTIONS BEFORE
USE; S45 IN CASE OF ACCIDENT/IF YOU FEEL UNWELL, SEEK MED (OTHER
INFO)
State Regulatory Information:CALIFORNIA PROPOSITION 65: WARNING: PROD
CONTAINS CHEMS KNOWN TO STATE OF CALIFORNIA TO CAUSE CANCER. SARA
REGS: LETHAL EFTS W/SUBCHRONIC EXPOS TO ACRYLAMIDE & N,
N'-METHYLENE BIS ACRYLAMIDE HAVE BEEN REPORTED IN LAB ANIMALS.
IMPAIRMENT OF VISUAL FUNC WAS OBSERVED IN FEMALE MONKEYS TREATED
W/ACRYLAMIDE (10 MG/KG BW). ACRYLAMIDE HAS PRDCED CHROMOSOME DMG AS
WELL AS MUTATIONS IN SEVERAL IN VITRO & I N VIVO TESTS.
N-METHYLOACRYLAMIDE HAS ALSO SHOWN CLEAR EVIDENCE OF CARCIN IN
EXPERIMENTAL ANIMALS IN A 2 YR NTP GAVAGE STUDY. FORMALDEHYDE HAS
CAUSED MUTATIONS & CHROMOSOME DMG IN MAMMALIAN CELLS & IN VIVO
TESTS. (EFTS OF OVEREXP)